Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tarsus Pharmaceuticals, Inc.

TARS Clue Score56

United States Fiscal year ends December CIK 0001819790 Results filed 3 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

24 insiders · 274 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bobak R. Azamian

President/CEO and Board Chair

—

$15.04M (88) scheduled

−$15.04M

1,709,403

3.90%

$136.77M

−19.0%

Rtw Investments, LP entity

10% owner

—

$13.49M (1)

−$13.49M

2,013,601

4.59%

$161.11M

−18.3%

Vivo Capital IX, LLC entity

10% owner

$4.00M (1)

$14.46M (10)

−$10.46M

8,701,367

19.83%

$696.20M

+39.6%

William J Phd Link

Director

—

$6.94M (16) scheduled

−$6.94M

1,206,788

2.75%

$96.56M

−3.2%

Frazier Life Sciences IX, L.P.

10% owner

$5.00M (1)

—

+$5.00M

1,917,157

4.37%

$153.39M

—

Dianne C. Whitfield

Chief Human Resources Officer

—

$3.36M (22) scheduled

−$3.36M

35,028

0.0798%

$2.80M

+1,675%

Horowitz Limited Partnership VIII entity

10% owner

$2.95M (2)

—

+$2.95M

1,987,105

4.53%

$158.99M

—

Aziz Mottiwala

Chief Commercial Officer

—

$2.87M (25)

−$2.87M

61,480

0.1401%

$4.92M

+8.3%

Jason E. Tester

Director

$2.75M (2)

—

+$2.75M

1,949,331

4.44%

$155.97M

—

Seshadri Neervannan

Chief Operating Officer

—

$2.54M (16)

−$2.54M

79,482

0.1811%

$6.36M

+41.9%

Jeffrey S Farrow

See Remarks

—

$2.33M (9)

−$2.33M

56,801

0.1294%

$4.54M

+8,014%

Elizabeth Yeu Lin

Chief Medical Officer

$456.31K (3)

$2.40M (12) scheduled

−$1.95M

32,043

0.0730%

$2.56M

+102.0%

Bryan Wahl

General Counsel

—

$1.67M (17)

−$1.67M

63,959

0.1457%

$5.12M

+537.0%

Leonard M. Greenstein

Chief Financial Officer

—

$708.04K (16)

−$708.04K

26,785

0.0610%

$2.14M

−61.3%

Michael Ackermann

Director

$1.35M (1)

$752.39K (16)

+$597.61K

1,308,273

2.98%

$104.67M

+12.2%

Katherine Goodrich

Director

—

$183.38K (1) scheduled

−$183.38K

2,233

0.0051%

$178.66K

—

Jose M. Trevejo

Chief Medical Officer

—

$113.02K (8) scheduled

−$113.02K

2,251

0.0051%

$180.10K

+40.3%

Andrew D. Goldberg

Director

$18.96K (1)

—

+$18.96K

19,654

0.0448%

$1.57M

—

Mark J. Holdbrook

V.P., Clinical Affairs

—

$7.50K (3)

−$7.50K

3,191

0.0073%

$255.31K

+187.2%

Wendy L Yarno

Director

—

—

—

16,956

0.0386%

$1.36M

—

Bhaskar Chaudhuri

Director

—

—

—

11,654

0.0266%

$932.44K

—

David E I Pyott

Director

—

—

—

10,958

0.0250%

$876.75K

+16.9%

Scott W Morrison

Director

—

—

—

7,638

0.0174%

$611.12K

—

Rosemary A Crane

Director

—

—

—

5,350

0.0122%

$428.05K

—